SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-045718
Filing Date
2024-04-19
Accepted
2024-04-19 07:44:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A kpti-defa14a-2024.htm DEFA14A 22817
2 GRAPHIC img184706078_0.jpg GRAPHIC 545571
3 GRAPHIC img184706078_1.jpg GRAPHIC 491361
  Complete submission text file 0000950170-24-045718.txt   1451592
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36167 | Film No.: 24855635
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)